elranatamab
pfizer
['magnetismm-3', 'mmsm', 'multiple myeloma', 'cll', 'elranatamab']
efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma na ve to b-cell maturation antigen (bcma)-directed therapies: results from cohort a of the magnetismm-3 study. dr. bahlis #ash22 #imfash22 #mmsm #myeloma 
Hematology is in my ??. Posts are mine. Mayo Clinic Associate, Asst Prof, BMT RNCC, RN Navigator, emeritus. IMF NLB. MM KOL. Patient educator & advocate.